CommunityConnect with experts, uncover more opportunities
1.66K
Selection
lucasL
·
2025-03-07
$Alibaba(BABA)$   Selling call options can seem like a straightforward way to generate income, especially when you own the underlying stock. However, my recent experience with Alibaba (BABA) has taught me that this strategy comes with significant risks, particularly when the market moves against you. Here’s my story and a cautionary tale about the dangers of selling call options. I held 300 shares of Alibaba, which I had purchased at $130 per share. Feeling confident about my position, I decided to sell 3 call option contracts with a strike price of $135, receiving a premium of $3 per share. At the time, this seemed like a great idea. I had an $8 buffer ($135 strike price minus my $130 purchase price plus the $
$Alibaba(BABA)$ Selling call options can seem like a straightforward way to generate income, especially when you own the underlying stock. However,...
TOPVenus Reade: there is one thing all BABA investors agree on, and that is that $141 is the bottom. There is only one way for it to go from here, and that is up.
6
Report
2.60K
General
PeterDiCarlo
·
2025-03-07

Daily Hot Stocks - PLTR, SPY & TSLA

1. $Palantir Technologies Inc.(PLTR)$ PLTR looked like it found a bottom yesterday… then Jim Cramer tweeted 😂Today’s bounce completely failed, and now the question is...where does PLTR go from here?2. $SPDR S&P 500 ETF Trust(SPY)$ SPY is dropping again, and this next level is criticalWe’re approaching a major support at $570, and in tonight’s video I break down why this could be a make-or-break moment. I’ll cover whether price is about to break structure, why a rebound could still be on the table, and how I’m protecting my portfolio heading into 2025.3. $Tesla Motors(TSLA)$ TSLA Drops Another 5% 📉 Is the Bottom Actually In?Yesterday, it looked like we might ha
Daily Hot Stocks - PLTR, SPY & TSLA
TOPAI_FocusedTrader: Tsla and PLTR are not performing well, interested to see what other people think about their current outlook
1
Report
1.02K
General
PeterDiCarlo
·
2025-03-07

Daily Hot Stocks - AMZN, GOOG, MSTR & NVDA

1. $Amazon.com(AMZN)$ AMZN is at a massive discount, but was yesterday’s bounce a trap?We saw signs of higher lows yesterday, but today’s sell-off raises questions. 2. $Alphabet(GOOG)$ $Alphabet(GOOGL)$ GOOG has been selling off hard, but something just changedFor three straight days, the BX Trender has made higher lows and buyers are stepping in while the rest of the market struggles.3. $Strategy(MSTR)$ MSTR is approaching one of the most critical closes in monthsIf the BX Trender confirms this Friday, this could mark the bottom. A breakout to $450 in the next 3-6 months is on the table.4.
Daily Hot Stocks - AMZN, GOOG, MSTR & NVDA
1
Report
13.04K
Selection
Tiger_Contra
·
2025-03-06

💰Stocks that bring both profit and interest in Healthcare Industry: AMGN/ABBV/JNJ

💰 Winning in chaos requires strong fundamentals!💹 $Amgen(AMGN)$/$AbbVie(ABBV)$/$Johnson & Johnson(JNJ)$: Here are the outperformers, who also offer astonishing dividend yields.📣 Stay tuned and supercharge purchasing power with CashBoost!America is back!In a prominent position on the White House official website, a carefully designed portrait of President Trump occupies the core area of the homepage, and the bold font "AMERICA IS BACK" creates a strong visual impact.On March 4, President Trump began his speech to the joint session of Congress with "America is back!" During the speech, the venue presented a clear bipartisan divide. Republicans frequently applaud
💰Stocks that bring both profit and interest in Healthcare Industry: AMGN/ABBV/JNJ
3
Report
889
Selection
Mickey082024
·
2025-03-06

Petrobras Earning Loses Steam Alongside Its Dividend?

$Petroleo Brasileiro SA Petrobras(PBR)$ Petrobras Update Good day, fellow Tiger. Petrobras has been riding roller coaster, though its performance hasn't been stellar lately. Looking at the stock from a long-term perspective, we've seen cycles of booms and busts driven by oil prices. Currently, Petrobras finds itself in a mid-range position, slightly weaker over the past five years and in recent periods. However, the key highlight is its dividend yield of 16%, P/E ratio of 11.55, and market cap of $48 billion. Let’s examine Petrobras' newly released strategic plan to see where the company is headed. A Unique Approach Compared to Wall Street One notable aspect of Petrobras’ strategy is how openly it acknowledges the long-term decline in oil demand. T
Petrobras Earning Loses Steam Alongside Its Dividend?
TOPValerie Archibald: Many US stocks will undoubtedly tumble in the week ahead. Hopefully PBR will get somewhat spared from cratering too badly.
2
Report
1.95K
Selection
Shernice軒嬣 2000
·
2025-03-06

The eye of the storm; Don’t be alarmed it gets much worse.

Trump’s Tariffs: Inflation Fears and Yield Pressure Donald Trump’s recent tariff moves—25% on imports from Canada and Mexico, plus an additional 10% on Chinese goods—have jolted global markets. Tariffs of this magnitude, targeting major U.S. trading partners, threaten to disrupt supply chains and raise the cost of imported goods. Economists estimate that a 10% tariff could shave 0.3% off eurozone growth annually unless offset by currency depreciation, while a 20% tariff might halve the region’s projected 1% growth for 2025. In the U.S., the impact could be a GDP drop of 1.3–1.5% in the first two years, though a stronger trade balance might mitigate this over time. The immediate concern for bond markets is inflation. Higher import costs could fuel price pressures, reducing the Federal Reser
The eye of the storm; Don’t be alarmed it gets much worse.
TOPAI_FocusedTrader: It’s very interesting to see how investors are looking at the recent news and developments!
4
Report
688
Selection
Mickey082024
·
2025-03-06

Salesforce Beats Earning but Forecasts Slower Growth

$Salesforce.com(CRM)$ Salesforce remains a dominant player in the CRM market, fueled by its expanding AI and Data Cloud capabilities. The company has demonstrated impressive growth, with its Data Cloud and AI annual recurring revenue reaching $900 million—marking a 120% year-over-year increase. Agentforce, a key AI-powered customer service tool, has gained strong traction, securing 5,000 deals since October, with over 3,000 being paid. Meanwhile, Data Cloud continues to scale rapidly, exceeding 50 trillion records—doubling year-over-year. Nearly half of the Fortune 100 companies now utilize both AI and Data Cloud, and all of Salesforce’s top 10 deals in Q4 incorporated AI and Data integration. Earning Overview In Q4 2025, Salesforce reported $10 bi
Salesforce Beats Earning but Forecasts Slower Growth
TOPAI_FocusedTrader: I’ve been paying attention to CRM for a while now! Seeing potential in this.
4
Report
2.42K
Hot
Barcode
·
2025-03-07
$Vaxcyte, Inc.(PCVX)$ $Madrigal Pharmaceuticals(MDGL)$ 💉💊📈🅱️ U͎ L͎ L͎ I͎ S͎ H͎💊💉 🚀 Biotech’s Big Bet, Vaxcyte ($PCVX), Madrigal ($MDGL) & 2025’s Healthcare Boom Markets are a pressure cooker in March 2025, with 10-year Treasury yields creeping toward 4.2%, PMI data flashing manufacturing weakness, and tariff threats rattling equities. Yet, Goldman Sachs’ David Kostin is doubling down on healthcare, a sector that has outperformed the S&P 500 by 7 points YTD while still trading at an 18% P/E discount, the widest in 20 years. With healthcare powering 17% of US GDP, it is the perfect defensive, offensive hybrid. That is why I am zooming in on two biotech powerhouses backed by Goldman Sachs. ✅ Vaxcyte
$Vaxcyte, Inc.(PCVX)$ $Madrigal Pharmaceuticals(MDGL)$ 💉💊📈🅱️ U͎ L͎ L͎ I͎ S͎ H͎💊💉 🚀 Biotech’s Big Bet, Vaxcyte ($PCVX), Madrigal ($MDGL) & 2025’s Healthcar...
TOPTigerAI: Here is the analysis of Vaxcyte, Inc. ($PCVX) and Madrigal Pharmaceuticals ($MDGL): Vaxcyte, Inc. ($PCVX) Business: Vaxcyte is a biotech company that disrupts vaccines with synthetic biology. It uses a cell-free protein synthesis platform to engineer next-gen bacterial vaccines with superior precision and immunogenicity. Earnings Forecast: The forecast for FY2025 and FY2026 shows negative EPS and significant losses. However, FY2027 is projected to have an EPS of -4.47 USD. Analyst Recommendation: 5 recommend, 6 buy. Analyst Target Price: The mean target estimate is 150.22 USD, with a low estimate of 135.00 USD and a high estimate of 163.00 USD. Capital Flow Data (5 Day): The capital flow data shows both inflows and outflows over the past five days, with the most recent day indicating an outflow of 1310.78 thousand units. Support Price (2025-03-05): 71.67 USD Resistance Price (2025-03-05): 86.37 USD Stock Price (2025-03-07): 74.495 USD Madrigal Pharmaceuticals ($MDGL) Business: Madrigal Pharmaceuticals dominates the first-ever NASH treatment market. Earnings Forecast: The forecast for FY2025 shows a negative EPS. However, FY2026 is projected to have an EPS of 2.15 USD, and FY2027 is projected to have an EPS of 22.99 USD. Analyst Recommendation: 5 recommend, 9 buy, 1 hold, 1 underperform. Analyst Target Price: The mean target estimate is 412.67 USD, with a low estimate of 239.00 USD and a high estimate of 539.00 USD. Capital Flow Data (5 Day): The capital flow data shows both inflows and outflows over the past five days, with the most recent day indicating an inflow of 3148.42 thousand units. Support Price (2025-03-05): 334.44 USD Resistance Price (2025-03-05): 347.44 USD Stock Price (2025-03-07): 338.49 USD In terms of risk-reward profile for a 3-year biotech hold, Vaxcyte ($PCVX) has a potential for multi-bagger returns if its Phase 3 trials succeed, with a significant upside from analyst targets. Madrigal Pharmaceuticals ($MDGL) offers more stable and predictable returns with a successful launch of Rezdiffra™. Please note that the above suggestions cannot be considered as investment advice. Investing in the stock market carries inherent risks and stock prices may fluctuate. It's important to conduct thorough research and analysis before making investment decisions. Sources: Vaxcyte, Inc. analysis: Link Madrigal Pharmaceuticals analysis: Link
25
Report
1.59K
Selection
nerdbull1669
·
2025-03-07

Nio (NIO) Return On Investment And Vehicle Sales TO Watch

$NIO Inc.(NIO)$ is expected to release their Q4 2024 quarterly result for period ending 31 December 2024 on 11 March 2025 (to be confirmed). Market expect NIO to show a rise in quarterly revenue of 17.9% increase in revenue to CNY20.163 billion from CNY17.1 billion a year ago. This is inline with the guidance given by NIO on 20 Nov 2024 which has the revenue between CNY19.68 billion and CNY20.38 billion. The earnings consensus estimate is expected to come in at a loss of CNY2.44 per share or 34 cents. Nio (NIO) Last Neutral Earnings Call Saw Share Price Decline By 8.42% NIO had a neutral earnings call on 20 Nov 2024 which saw the share price decline by 8.42% since. The earnings call highlighted strong vehicle delivery performance, positive cash flo
Nio (NIO) Return On Investment And Vehicle Sales TO Watch
TOPAnaiAnai: Are you sure it is on 11th March ? So far Nio hasn't released any date yet. Someone said on 4th March too. All are predicting the date?
5
Report
1.10K
General
ToNi
·
2025-03-07

Analyzing Broadcom (AVGO) Stock: Opportunities and Challenges Amid Market Volatility

As of March 6, 2025, Broadcom (AVGO), a leading semiconductor and networking equipment giant, has experienced a rollercoaster day on the stock market, offering both opportunities and challenges for investors. With a post-market trading price of $179.45 after a 6.33% drop during regular trading, followed by a striking 10.54% rebound, the stock’s volatility reflects a mix of macroeconomic pressures and company-specific developments. Let’s break it down.  Market Performance and Technical Insights The day’s regular trading saw AVGO decline by $12.13, closing at $179.45, influenced by broader market concerns, including potential tariffs under the Trump administration and a lackluster performance from rival Marvell Technology. However, the post-market surge of $18.91 was triggered by Broadc
Analyzing Broadcom (AVGO) Stock: Opportunities and Challenges Amid Market Volatility
TOPVenus Reade: It will be $275-$300 by years end
5
Report
982
General
Tiger V
·
2025-03-07

Markets Wobble as US Pullback Deepens

Market Overview Global markets showed mixed performances as US stocks extended their sharp pullback despite concessions on tariffs, while European and Asian markets found relief from positive policy signals and tariff delays. Uncertainty around US trade policies and investor sentiment continues to drive volatility across major indices. US: Steep Decline Continues Amid Trade Uncertainty US markets fell sharply as investor concerns over President Donald Trump's controversial tariff policies persisted. Despite White House concessions, the Dow Jones $DJIA(.DJI)$  dropped 427.51 points (-0.9%) to 42,579.08, while the S&P 500 $S&P 500(.SPX)$  <
Markets Wobble as US Pullback Deepens
TOPNicoleBryce: Great insights, love this analysis! [Great]
3
Report
1.50K
Selection
nerdbull1669
·
2025-03-07

Oracle (ORCL) Revenue Growth From AI To Watch

$Oracle(ORCL)$ will be reporting its quarterly earnings result for period for fiscal Q3 2025 on 10 March 2025 after market close. ORCL is expected to post an earnings per share at $1.49 per share, this would represent an increase of 5% compared to same period one year ago. Revenues is forecast to come in at $14.36 billion, representing an increase of 8.1% year over year. Oracle (ORCL) Last Positive Earnings Call Saw A Decline Of 20.55% ORCL had a positive earnings call on 09 Dec 2024 but the share price saw a decline of 20.55% since then. The earnings call highlighted strong growth in cloud revenue, particularly in AI demand and infrastructure, and a significant increase in remaining performance obligations, indicating robust future revenue. Howev
Oracle (ORCL) Revenue Growth From AI To Watch
TOPAI_FocusedTrader: thanks for sharng, that’s comprehensive and insightful, ORCL is suitable for long-term investment
5
Report
2.28K
General
SmartReversals
·
2025-03-07

SPX has reached the 200DMA amidst extreme fear

$S&P 500(.SPX)$ has reached the 200-day moving average (DMA) amidst extreme fear, a level not seen since the 10% correction in October 2023. The Bollinger Bands are widening and the lower one looks like a slider ➡️The hope for a bounce is in the pink line and its confluence with $5739, a level shared last Friday. Any bounce has to recover $5812, the level that rejected the bounce today.Imagehis is from a previous year, if you remember this chart, it means you survived 2022 and you didn't throw the towel and continued trading/investing. ➡️Where are we? A or B?Image
SPX has reached the 200DMA amidst extreme fear
TOPAI_FocusedTrader: The latest market is very interesting to watch, keep sharing amazing analysis!
1
Report
1.75K
General
TopdownCharts
·
2025-03-07

Chart of the Week - LatAm Deep Value

In the age of the “everything bubble”, it’s not often that you come across a chart saying something is outright cheap, or even near-record lows for that matter…And I know what you might be thinking — “it’s cheap for a reason“ or “it’s a value trap“ or maybe even “valuations don’t matter“.And there are situations where either or all 3 of those claims can genuinely apply.For example, “cheap for a reason“ is almost always true, because most of the time when an asset or market is cheap it’s because of a cyclical deterioration in fundamentals, or some kind of shock/crisis, or some other logical reason. A lot of the time that deterioration is transitory, and markets often overreact to that deterioration — driving valuations down further than they really should be (aka opportunities).Meanwhile “i
Chart of the Week - LatAm Deep Value
TOPAI_FocusedTrader: I agree with your points! Thanks for sharing
1
Report
5.47K
General
Travis Hoium
·
2025-03-07

Democratizing “Rich People Sh*t” As a Business Model

Making stuff for rich people accessible to the masses hasn’t often been an explicit part of the business model for companies. But I’m hearing it more and more.It was this interview with Vlad Tenev from $Robinhood(HOOD)$ that piqued my interest in the company and ultimately drove me to add Robinhood to the Asymmetric Portfolio last year. He said in part:The idea behind Robinhood Gold is, if you’re a high net worth individual and you’re accustomed to a level of service from your bank or financial institution, we want to open up that private client, high net worth experience for just $5 per month to the mass market.Vlad Tenev, Robinhood CEOTaken with that lens, Robinhood’s strategy of adding more services to Gold and leveraging its lower cost structu
Democratizing “Rich People Sh*t” As a Business Model
TOPTiger_CashBoostAccount: Great job on your latest stock market success! Your commitment to research and analysis is evident in your results.Trade with Tiger Cash Boost Account and use contra trading toenhance your strategies."Welcome to open a CBAtoday and enjoy access to a trading limit of up to SGD 20,000with upcoming 0-commission, unlimited trading on SG, HKand US stocks. as well as ETFs. How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
3
Report
6.35K
General
Bixley
·
2025-03-07

BTCUSD - Bull Extension

BTCUSD - Bull ExtensionBTCUSD: BTCUSD - Bull Extension Price right now has relatively been contained within an upward channel In this chart i suggest a breakout of this trend line / channel and extension up to create a new ATH for this bull run I have used the bars pattern from the 2016 - 17 run Lets see what happens. Daily chartBTCUSD - Similar ChannelsBTCUSD: BTCUSD - Similar Channels Current channel can be contrasted to the previous 2017 run We are at the stage before aggressive bulls take control pushing above this channel The verge of a large breakout for crypto across the board I don't know if price will surpass 1m but it
BTCUSD - Bull Extension
TOPAI_FocusedTrader: The crypto summit promises to provide much changes! Excited to see what lies ahead for BTC
1
Report
5.02K
Selection
OptionsDelta
·
2025-03-07

Wall Street Floor Large Orders: NVIDIA Year-End Lowest Expectation at 146

$NVIDIA(NVDA)$ The "2 Billion" trader rolled over their April 120 call to June 120 call $NVDA 20250620 120.0 CALL$ .The strike price remains unchanged, and the transaction volume is consistent, suggesting that the Q2 market is expected to mirror Q1.On Wednesday, open interest rankings saw significant changes. For call options: $NVDA 20250620 120.0 CALL$  added 100,000 contracts, ranking fourth; weekly expiration 120 calls saw a surge in opening volume; 130 calls closed over 15,000 contracts.Regarding put options: March monthly 120 puts rolled over into recent bearish positions. June expiration 90 puts added 30
Wall Street Floor Large Orders: NVIDIA Year-End Lowest Expectation at 146
TOPTiger_CashBoostAccount: Great job on your latest stock market success! Your commitment to research and analysis is evident in your results.Trade with Tiger Cash Boost Account and use contra trading toenhance your strategies."Welcome to open a CBAtoday and enjoy access to a trading limit of up to SGD 20,000with upcoming 0-commission, unlimited trading on SG, HKand US stocks. as well as ETFs. How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
2
Report
10.33K
Selection
JC888
·
2025-03-06

BBAI - Buy on eve of Quarterly Earnings ?

The Mild Rise. On Wed, 05 Mar 2025, $BigBear.ai Holdings(BBAI)$ shares fell as much as -3.0% intraday. Thankfully, by the time 4pm came around, it closed higher at +1.91%, ahead of the company’s Q4 quarter earnings that will be released after the closing bell on Thursday. (see below) BBAI has been trending downwards since news broke that the Trump administration directed the Department of Defense (DOD) to cut $50 billion in spending. This worked out to be about 6% of the total defense budget and in the process, dampened retail sentiment. The move raises concerns for defense contractors like BBAI, that relies heavily on government contracts. Quarterly Earnings - Past & Forecast. The AI solutions provider has struggled with profitability, postin
BBAI - Buy on eve of Quarterly Earnings ?
TOPTiger_CashBoostAccount: Great job on your latest stock market success! Your commitment to research and analysis is evident in your results.Trade with Tiger Cash Boost Account and use contra trading toenhance your strategies."Welcome to open a CBAtoday and enjoy access to a trading limit of up to SGD 20,000with upcoming 0-commission, unlimited trading on SG, HKand US stocks. as well as ETFs. How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
7
Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24